| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Tumor Immunology and Biology, Division of Cancer Biology, Diagnosis and Centers, National Cancer Institute, NIH, Bethesda, Maryland 20892
Human prostate-specific antigen (PSA) has been shown as an aid in the early detection of prostate cancer (W. J. Catalona et al., J. Am. Med. Assoc., 270: 948–954, 1993) and was approved in 1994 by the Food and Drug Administration for early detection of prostate cancer. Immunotherapies directed against PSA have been suggested in patients with metastatic prostate cancer. One of the essential questions is to define which nonhuman species express PSA for experimental studies. Using Southern blot analyses, genes related to human PSA have been detected in several nonhuman primate species, including chimpanzee, orangutan, gorilla, macaque, and rhesus monkey, but not in other mammalian species, including rabbit, cow, pig, dog, rat, or mouse. Immunohistochemical staining with anti-human PSA antisera detected strong staining in both human and monkey prostatic epithelial cells with no reactivity to rat prostate cells. Because the PSA gene is not present in the murine genome, a matched set of murine cell lines has been developed that may be useful to study the biochemical functions of PSA and as an experimental target for PSA-directed immunotherapy. To establish such cell lines, a C57BL/6 murine colon adenocarcinoma cell line, MC-38, was transfected with a retroviral vector containing cDNA encoding the human PSA gene. Genetic analysis of a PSA-secreting clone, PSA/MC-38, demonstrated that the PSA gene had been stably integrated into the MC-38 genome. The PSA/MC-38 cell line was found to secrete PSA into tissue culture medium, producing a protein of approximately Mr 30,000. In vivo, PSA/MC-38 grew as a s.c. tumor in male and female mice. PSA/MC-38 tumors grew more rapidly in athymic mice than in syngeneic C57BL/6 mice, and in both mouse strains, the PSA/MC-38 tumors grew more slowly than control vector-transduced tumors. PSA was detected in the serum and tumors of PSA/MC-38 tumor-bearing mice. It is proposed that PSA/MC-38 cells may be used as a murine tumor model to test potential therapeutic vaccines and other experimental therapies directed against PSA.
1 To whom requests for reprints should be addressed, at National Cancer Institute, NIH, Building 10, Room 8B07, Bethesda, MD 20892.
Received 12/ 8/94. Accepted 3/30/95.
This article has been cited by other articles:
|
|
 |
|
  I. Sato, A. Yoshikawa, A. Ishiwari, and K. Shimizu Seasonal Changes in Urinary Prostate-Specific Antigenic Activity in Male Japanese Macaques (Macaca fuscaa fuscata) J Androl, November 1, 2007; 28(6): 821 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Williams, R. F. Merchant, E. Garrett-Mayer, J. T. Isaacs, J. T. Buckley, and S. R. Denmeade A Prostate-Specific Antigen-Activated Channel-Forming Toxin as Therapy for Prostatic Disease J Natl Cancer Inst, March 7, 2007; 99(5): 376 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Suttie, G. E. Dinse, A. Nyska, G. J. Moser, T. L. Goldsworthy, and R. R. Maronpot An Investigation of the Effects of Late-Onset Dietary Restriction on Prostate Cancer Development in the TRAMP Mouse Toxicol Pathol, April 1, 2005; 33(3): 386 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Wu, K. Esuvaranathan, and R. Mahendran Monitoring the Response of Orthotopic Bladder Tumors to Granulocyte Macrophage Colony-Stimulating Factor Therapy Using the Prostate-Specific Antigen Gene as a Reporter Clin. Cancer Res., October 15, 2004; 10(20): 6977 - 6984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Gallardo-Williams, R. E. Chapin, P. E. King, G. J. Moser, T. L. Goldsworthy, J. P. Morrison, and R. R. Maronpot Boron Supplementation Inhibits the Growth and Local Expression of IGF-1 in Human Prostate Adenocarcinoma (LNCaP) Tumors in Nude Mice Toxicol Pathol, January 1, 2004; 32(1): 73 - 78. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Heiser, P. Dahm, D. R. Yancey, M. A. Maurice, D. Boczkowski, S. K. Nair, E. Gilboa, and J. Vieweg Human Dendritic Cells Transfected with RNA Encoding Prostate-Specific Antigen Stimulate Prostate-Specific CTL Responses In Vitro J. Immunol., May 15, 2000; 164(10): 5508 - 5514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Eder, P. W. Kantoff, K. Roper, G. Xu, G. J. Bubley, J. Boyden, L. Gritz, G. Mazzara, W. K. Oh, P. Arlen, et al. A Phase I Trial of a Recombinant Vaccinia Virus Expressing Prostate-specific Antigen in Advanced Prostate Cancer Clin. Cancer Res., May 1, 2000; 6(5): 1632 - 1638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Liu, M. P. Patricelli, and B. F. Cravatt Activity-based protein profiling: The serine hydrolases PNAS, December 21, 1999; 96(26): 14694 - 14699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. G. Bussemakers, A. van Bokhoven, G. W. Verhaegh, F. P. Smit, H. F. M. Karthaus, J. A. Schalken, F. M. J. Debruyne, N. Ru, and W. B. Isaacs DD3::A New Prostate-specific Gene, Highly Overexpressed in Prostate Cancer Cancer Res., December 1, 1999; 59(23): 5975 - 5979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-C. Yu, G. T. Sakamoto, and D. R. Henderson Identification of the Transcriptional Regulatory Sequences of Human Kallikrein 2 and Their Use in the Construction of Calydon Virus 764, an Attenuated Replication Competent Adenovirus for Prostate Cancer Therapy Cancer Res., April 1, 1999; 59(7): 1498 - 1504. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
